We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SALM:EURONEXT OSLOSalMar ASA Analysis

Data as of 2026-03-11 - not real-time

$0.53

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Salem Media Group (SALM) is trading at $0.53, just above its technical resistance of $0.53 and only $0.13 above a solid support at $0.40. The stock shows a bullish MACD signal and an RSI of 71, indicating it is technically overbought, while volume is increasing and 30‑day volatility is extremely high at 72 %. Fundamentals are weak: revenue fell 12.6 % YoY, gross margin is a meager 4.8 %, operating margin is negative ‑11.5 %, and the company carries $55.9 M of debt against a market cap of only $16.9 M, yielding a debt‑to‑equity of 30 ×. Earnings are negative with a forward PE of ‑52.98 and a price‑to‑book of 0.09, suggesting the market is pricing in distress. The Fear & Greed Index sits at 78.16 (Extreme Greed), but the underlying financial health does not support such optimism. Recent leadership changes following the retirement of long‑time executive Val Carolin add uncertainty to the strategic direction.
Given the confluence of an overbought technical setup, high volatility, and deteriorating fundamentals, short‑term price pressure is likely, while the deep discount to book value leaves a modest long‑term upside if the company can restructure its balance sheet and stabilize cash flows.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI overbought at 71
  • Price at technical resistance
  • Extreme short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Negative margins and cash flow
  • High debt relative to market cap
  • Uncertainty from recent leadership change

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Deep discount to book value (P/B 0.09)
  • Niche audience with stable revenue streams
  • Potential asset monetization or restructuring

Key Metrics & Analysis

Financial Health

Revenue Growth-12.60%
Profit Margin-0.62%
P/E Ratio-53.0
ROE-0.86%
ROA-3.08%
Debt/Equity30.05
P/B Ratio0.1
Op. Cash Flow$-4633000
Free Cash Flow$-4595125
Industry P/E18.2

Technical Analysis

TrendNeutral
RSI71.0
Support$0.40
Resistance$0.53
MA 20$0.43
MA 50$0.42
MA 200$0.71
MACDBullish
VolumeIncreasing
Fear & Greed Index78.16

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.67
Volatility72.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.